Touchstone International Medical Science Co., Ltd. (688013.SS)
CNY 18.61
(-0.59%)
CNY 18.61
(-0.59%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -209.57 Million CNY | -553.08% |
| 2022 | -32.09 Million CNY | 57.45% |
| 2021 | -75.41 Million CNY | 40.51% |
| 2020 | -126.78 Million CNY | -572.89% |
| 2019 | -18.84 Million CNY | -97.97% |
| 2018 | -9.51 Million CNY | 58.42% |
| 2017 | -22.88 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -74.12 Million CNY | 62.26% |
| 2024 Q3 | -33.93 Million CNY | 54.5% |
| 2024 Q1 | -196.4 Million CNY | 6.29% |
| 2023 Q2 | -172.96 Million CNY | -473.59% |
| 2023 FY | -209.57 Million CNY | -553.08% |
| 2023 Q4 | -209.57 Million CNY | -21.31% |
| 2023 Q3 | -172.76 Million CNY | 0.12% |
| 2023 Q1 | -30.15 Million CNY | 6.03% |
| 2022 Q3 | -208.58 Million CNY | 10.12% |
| 2022 Q2 | -232.07 Million CNY | -40.29% |
| 2022 Q1 | -165.42 Million CNY | -119.35% |
| 2022 FY | -32.09 Million CNY | 57.45% |
| 2022 Q4 | -32.09 Million CNY | 84.61% |
| 2021 Q3 | -52.92 Million CNY | -9.77% |
| 2021 Q1 | -58.63 Million CNY | 53.75% |
| 2021 Q2 | -48.21 Million CNY | 17.77% |
| 2021 Q4 | -75.41 Million CNY | -42.49% |
| 2021 FY | -75.41 Million CNY | 40.51% |
| 2020 Q3 | -265.18 Million CNY | -723.21% |
| 2020 Q4 | -126.78 Million CNY | 52.19% |
| 2020 Q2 | -32.21 Million CNY | -269.22% |
| 2020 Q1 | 19.03 Million CNY | 201.04% |
| 2020 FY | -126.78 Million CNY | -572.89% |
| 2019 FY | -18.84 Million CNY | -97.97% |
| 2019 Q4 | -18.84 Million CNY | 0.0% |
| 2019 Q1 | 21.97 Million CNY | 0.0% |
| 2018 FY | -9.51 Million CNY | 58.42% |
| 2017 FY | -22.88 Million CNY | 0.0% |